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1119: DIFFERENTIAL EXPRESSION AND FUNCTION OF MONOCARBOXY-
LATE TRANSPORTER 1 (MCT1) IN HUMAN COLON
Naomi Fearon*,1, Elizabeth Ryan 1, Gavin Stewart 2, Des Winter 1,
Alan Baird 2. 1St Vincents University Hospital, Dublin, Ireland; 2University
College Dublin, Dublin, Ireland.
Introduction: Butyrate, a short-chain fatty acid, is produced by fermen-
tative bacteria in the colon, and is the primary energy source for colono-
cytes. It is transported across the colonic epithelium by monocarboxylate
transporter 1(MCT1). Optimal butyrate production and transport is
imperative for maintenance of gut health.
Methods: Western blot studies and immunohistochemistry detected
expression of MCT1 transporters in the human colon. Butyrate ﬂux studies
were carried out by mounting fresh human colon samples in Using
Chambers. Bidirectional ﬂux was investigated using radiolabelled butyrate
(C14) and Papp determined by using a scintillation counter.
Results: Immunohistochemistry andWestern blotting showed differential
expression of MCT1 throughout the colon. There was stronger expression
in the ascending colon compared to the descending colon (p<0.01, n¼3).
Butyrate ﬂux was bidirectional and was signiﬁcantly greater in the
ascending colon compared to the descending colon (p<0.05, n¼6). Flux
was inhibited by the known butyrate inhibitor Resveratrol.
Conclusions: These results illustrate differential expression of MCT1 in the
human colon, strongly correlating to regions that contain the largest
populations of intestinal bacteria.
1126: COLORECTAL CANCER OPERATIVE NOTES: PRELIMINARY AUDIT
RESULTS
Jessica Veitch*, Thomas Barnes, Nicola Eardley, Michael Johnson,
Chris McFaul, Dale Vimalachandran. Countess of Chester NHS Foundation
Trust, Chester, UK.
Introduction: Structured operative notes are imperative to provide clear
documentation of intraoperative events. In colorectal cancer they are vital
to plan post-operative management and future follow-up as well as aiding
data collection. This audit will assess colorectal cancer operative note
documentation in accordance with Association of Coloproctology (ACP)
Guidelines.
Methods: 50 colorectal resections performed between September 2012
and September 2013 were randomly selected for audit and operative notes
reviewed retrospectively. From these results an operative note proforma
was produced in accordance with ACP guidelines. A re-audit is ongoing
auditing all resections performed since November 2013 with this proforma
in use. Preliminary second cycle results are presented (n¼15).
Results: Full name, DOB and hospital number documentation improved
from 51%, 31% and 39% respectively to 100% each in the second cycle.
Surgeon name was 100% in both cycles though surgeon grade improved
from 2% to 87%. Operation date improved from 71% to 100% and start/end
time improved from 0% to 87%. Operation intention improved from 16% to
87%. Extent of malignancy improved from 61% to 87%.
Conclusions: Preliminary results show that an operative note proforma
has improved documentation in all domains. On-going audit is required to
conﬁrm this.
1139: THE ADDITIONAL YIELD OF WHOLE COLONIC IMAGING TWO
WEEK RULE (TWR) COLORECTAL ASSESSMENT
Nadeem Al-Khafaji*,2, Leonard Quinn 1, Adnan Sheikh 1, Paul Rooney 1.
1Royal Liverpool University Hospital, Liverpool, UK; 2University of Liverpool,
Liverpool, UK.
Introduction: Whole Colonic Investigation (WCI) following negative
Flexible Sigmoidoscopy (FS) in symptomatic patients is thought to have a
low diagnostic yield. We assessed the adequacy of FS in symptomatic TWR
patients and additional yield of neoplasia gained with WCI.
Methods: 2151 TWR patients from January 2012 to June 2013 were ana-
lysed, 404 excluded for non-attendance and anaemia. Endpoints were age-
stratiﬁed FS outcomes and additional colonic/extra-colonic neoplastic
yield of WCI.
Results: 1747 symptomatic patients were included (median age 65) with
91 colorectal cancers. WCI was undertaken in 974(55.8%) patients
following FS. FS initially identiﬁed 285 patients with colorectal neoplasia.Subsequent WCI identiﬁed 112 additional patients. The additional yield of
WCI compared to FS was signiﬁcantly greater, 29 in the 70-79year group
(p¼0.006), 41 in the 60-69year group (p¼0.001) and 28 in the 50-59 year
group (p¼0.01) (Chi-square). In >80year and <49year groups, WCI did not
confer signiﬁcant beneﬁt. 15 missed colorectal and 40 extra-colonic pri-
maries were identiﬁed by WCI.
Conclusions: WCI identiﬁed signiﬁcant numbers of patients with colo-
rectal neoplasia following negative FS. Investigating with FS alone results
in unacceptably high missed colonic and extra-colonic cancers. The role of
FS alone in colorectal TWR workup needs reassessment.
1157: COLORECTAL CANCER IN THE ELDERLY AND THE INFLUENCE OF
LEAD TIME BIAS: BETTER SURVIVAL DOES NOT EQUATE WITH
IMPROVED LIFE EXPECTANCY
K. Knight*, R. Oliphant, F. Maxwell, C. McKenzie, T. Sharma, A. Macdonald.
Lanarkshire Colorectal Study Group, Monklands Hospital, Airdrie, UK.
Introduction: To deﬁne outcomes in all patients presenting with colorectal
cancer aged 80 years at time of diagnosis based on treatment received.
Methods: Patients aged80 diagnosed with colorectal cancer in one acute
hospital trust between 1998 and 2011 were identiﬁed from a prospectively
maintained database. Primary endpoints were age at diagnosis, age at
death/censor and mortality at 30, 90 and 365 days.
Results: Of 668 patients, 412 (61.7%) underwent surgery, 44 (6.6%)
received endoscopic therapy and 212 (31.7%) had no active treatment.
Mean age at diagnosis was younger in those undergoing surgical resection
(83.7 years) compared to those having defunctioning surgery (84.9 years;
P¼0.043), endoscopic therapy (85.1 years; P¼0.008) or those managed
non-surgically (85.6 years; P<0.001). There was no signiﬁcant difference in
mean age of death or censor between groups. 1-year mortality in those
undergoing surgical resection was 30.1% compared to 67.7% in the
defunctioning group, 76.9% after bypass surgery and 63.2% in those who
had no active treatment (Log rank P<0.001).
Conclusions: There was no signiﬁcant difference in age at death or censor
between treatment groups among patients aged 80 presenting with
colorectal cancer, suggesting that differences in observed survival time are
heavily inﬂuenced by lead-time bias.
1233: I’D RATHER TAKE THE STAIRS e AN ALTERNATIVE TO CARDIOPUL-
MONARY EXERCISE TESTING
Alastair Morton*,1, Charles Maxwell-Armstrong 2, Damian Bragg 2,
Chris Harber 2. 1University of Nottingham, Nottingham, UK; 2Nottingham
University Hospitals Trust, Nottingham, UK.
Introduction: To investigate whether a short exercise test and peak
expiratory ﬂow rate (PEFR) can predict post-operative complications in
elective major abdominal surgery.
Methods: 58 patients scheduled for major abdominal surgery aged over 40
were recruited. In addition to the normal preoperative evaluation, patients'
rates of heart rate recovery (HRR) were recorded for twominutes following
a rapid climb of two ﬂights of stairs. Preoperative and postoperative PEFR,
incidence of complications and length of stay (LOS) were recorded.
Results: 48 patients were suitable for analysis; 40 had valid HRR data.
Complications occurred in 24/48 patients (50%). The mean rate of HRR was
signiﬁcantly lower in those who subsequently developed complications
(2.880±1.577 b.p.m/15secs) compared to those who did not (4.493±1.306
b.p.m/15secs) (t (38)¼3.473, p¼0.001), a mean difference of 1.614 (95%CI
0.673-2.554). When adjusted for severity of complication, the R2 value of
association was 0.371 (p<0.001). In patients with co-morbidities, preop-
erative PEFR was 29.7% lower in those who developed complications
(p¼0.022, 95% CI 5.09%-54.31%).
Conclusions: The HRR rate is a quick and cheap alternative to cardiopul-
monary exercise testing to screen for post-operative complication risk.
More data is needed to assess the impact on LOS. PEFR was predictive of
complications in those with co-morbidities.
1248: SURGEON VERSUS GASTROENTEROLOGY COLONOSCOPISTS e DO
SURGEONS NEED TO TRAIN IN ENDOSCOPY?
Qamar Zaman*,1, Aftab Khan 2, Daniel Thomas 1, Rajab Kerwat 1,
Hamid Khawaja 1, John Payne 1. 1Queen Mary Hospital, London, UK;
2University College London, London, UK.
Introduction: To compare the colonoscopy service provision between
gastroenterologists and surgeons at a district general hospital.
